[1]
|
Blanchard A, Bockenhauer D, Bolignano D, et al. Gitel-man syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Contro-versies Conference[J]. Kidney Int, 2017, 91: 24-33. doi: 10.1016/j.kint.2016.09.046 |
[2]
|
Gitelman综合征诊治专家共识协作组. Gitelman综合征诊治专家共识[J]. 中华内科杂志, 2017, 56: 712-716. doi: 10.3760/cma.j.issn.0578-1426.2017.09.021 |
[3]
|
Graham AJ, Gelfand G, McFadden SD, et al. Levels of evidence and grades of recommendations in general thoracic surgery[J]. Can J Surg, 2004, 47: 461-465. http://europepmc.org/articles/PMC3211591/pdf/20041200s00014p461.pdf |
[4]
|
中华医学会内科学分会, 王建祥, 张奉春, 等. 中国成人血小板减少症诊疗专家共识[J]. 中华内科杂志, 2020, 59: 498-510. doi: 10.3760/cma.j.cn112138-20200424-00419 |
[5]
|
Jones J, Hunter D. Consensus methods for medical and health services research[J]. BMJ, 1995, 311: 376-380. doi: 10.1136/bmj.311.7001.376 |
[6]
|
Zhang L, Peng X, Zhao B, et al. Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort[J]. Nephrology (Carlton), 2020, 25: 749-757. doi: 10.1111/nep.13743 |
[7]
|
Tseng MH, Yang SS, Hsu YJ, et al. Genotype, pheno-type, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation[J]. J Clin Endocrinol Metab, 2012, 97: E1478-E1482. doi: 10.1210/jc.2012-1707 |
[8]
|
Bulucu F, Vural A, Yenicesu M, et al. Association of Gitelman's syndrome and focal glomerulosclerosis[J]. Nephron, 1998, 79: 244. doi: 10.1159/000045043 |
[9]
|
Rosado Rubio C, Fraile Gómez P, Gómez Muñoz MA, et al. C1q nephropathy in a patient with Gitelman syndrome[J]. NDT Plus, 2011, 4: 392-393. http://www.scienceopen.com/document_file/d68aa916-441e-4561-92f5-54f3b8a8b0af/PubMedCentral/d68aa916-441e-4561-92f5-54f3b8a8b0af.pdf |
[10]
|
Hanevold C, Mian A, Dalton R. C1q nephropathy in association with Gitelman syndrome: a case report[J]. Pediatr Nephrol, 2006, 21: 1904-1908. doi: 10.1007/s00467-006-0261-9 |
[11]
|
Chen Q, Wu Y, Zhao J, et al. A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 Gene[J]. BMC Nephrol, 2018, 19: 275. doi: 10.1186/s12882-018-1083-2 |
[12]
|
Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders[J]. Kidney Int, 2021, 99: 324-335. doi: 10.1016/j.kint.2020.10.035 |
[13]
|
Shao L, Ren H, Wang W, et al. Novel SLC12A3 muta-tions in Chinese patients with Gitelman's syndrome[J]. Nephron Physiol, 2008, 108: 29-36. doi: 10.1159/000117815 |
[14]
|
Qin L, Shao L, Ren H, et al. Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome[J]. Nephrology (Carlton), 2009, 14: 52-58. doi: 10.1111/j.1440-1797.2008.01042.x |
[15]
|
Miao M, Zhao CQ, Wang XL, et al. Clinical and genetic analyses of Chinese patients with Gitelman syndrome[J]. Genet Mol Res, 2016. doi: 10.4238/gmr.15027859. |
[16]
|
Wang F, Shi C, Cui Y, et al. Mutation profile and treatment of Gitelman syndrome in Chinese patients[J]. Clin Exp Nephrol, 2017, 21: 293-299. doi: 10.1007/s10157-016-1284-6 |
[17]
|
Liu T, Wang C, Lu J, et al. Genotype/phenotype analysis in 67 Chinese patients with Gitelman's syndrome[J]. Am J Nephrol, 2016, 44: 159-168. doi: 10.1159/000448694 |
[18]
|
Ma J, Ren H, Lin L, et al. Genetic features of Chinese patients with Gitelman syndrome: sixteen novel SLC12A3 mutations identified in a new cohort[J]. Am J Nephrol, 2016, 44: 113-121. doi: 10.1159/000447366 |
[19]
|
Zeng Y, Li P, Fang S, et al. Genetic analysis of SLC12A3 gene in Chinese patients with Gitelman syndrome[J]. Med Sci Monit, 2019, 25: 5942-5952. doi: 10.12659/MSM.916069 |
[20]
|
Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman syndrome[J]. J Am Soc Nephrol, 2011, 22: 693-703. doi: 10.1681/ASN.2010090907 |
[21]
|
Glaudemans B, Yntema HG, San-Cristobal P, et al. Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome[J]. Eur J Hum Genet, 2012, 20: 263-270. doi: 10.1038/ejhg.2011.189 |
[22]
|
Peng X, Zhao B, Zhang L, et al. Hydrochlorothiazide test as a tool in the diagnosis of Gitelman syndrome in Chinese patients[J]. Front Endocrinol (Lausanne), 2018, 9: 559. doi: 10.3389/fendo.2018.00559 |
[23]
|
Nozu K, Iijima K, Nozu Y, et al. A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome[J]. Pediatr Res, 2009, 66: 590-593. doi: 10.1203/PDR.0b013e3181b9b4d3 |
[24]
|
Nozu K, Nozu Y, Nakanishi K, et al. Cryptic exon activation in SLC12A3 in Gitelman syndrome[J]. J Hum Genet, 2017, 62: 335-337. doi: 10.1038/jhg.2016.129 |
[25]
|
Lo YF, Nozu K, Iijima K, et al. Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome[J]. Clin J Am Soc Nephrol, 2011, 6: 630-639. doi: 10.2215/CJN.06730810 |
[26]
|
Nagano C, Nozu K, Morisada N, et al. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases[J]. Clin Exp Nephrol, 2018, 22: 881-888. doi: 10.1007/s10157-018-1534-x |
[27]
|
Tavira B, Gómez J, Santos F, et al. A labor- and cost-effective non-optical semiconductor (Ion Torrent) next-generation sequencing of the SLC12A3 and CLCNKA/B genes in Gitelman's syndrome patients[J]. J Hum Genet, 2014, 59: 376-380. doi: 10.1038/jhg.2014.37 |
[28]
|
Ashton EJ, Legrand A, Benoit V, et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies[J]. Kidney Int, 2018, 93: 961-967. doi: 10.1016/j.kint.2017.10.016 |
[29]
|
Hureaux M, Ashton E, Dahan K, et al. High-throughput sequencing contributes to the diagnosis of tubulopathies and familial hypercalcemia hypocalciuria in adults[J]. Kidney Int, 2019, 96: 1408-1416. doi: 10.1016/j.kint.2019.08.027 |
[30]
|
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17: 405-424. doi: 10.1038/gim.2015.30 |
[31]
|
Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome[J]. J Am Soc Nephrol, 2007, 18: 1271-1283. doi: 10.1681/ASN.2006101095 |
[32]
|
De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, et al. Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome[J]. J Am Soc Nephrol, 2002, 13: 1442-1448. doi: 10.1097/01.ASN.0000017904.77985.03 |
[33]
|
Kunchaparty S, Palcso M, Berkman J, et al. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome[J]. Am J Physiol, 1999, 277: F643-F649. http://www.researchgate.net/profile/Gary_Desir/publication/12784778_Defective_processing_and_expression_of_the_thiazide-sensitive_Na-Cl_cotransporter_as_a_cause_Gitelman%27s_Syndrome/links/554390a00cf234bdb21bd1ce.pdf |
[34]
|
Sabath E, Meade P, Berkman J, et al. Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease[J]. Am J Physiol Renal Physiol, 2004, 287: F195-F203. doi: 10.1152/ajprenal.00044.2004 |
[35]
|
Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders[J]. Clin J Am Soc Nephrol, 2007, 2: 454-460. doi: 10.2215/CJN.02950906 |
[36]
|
彭晓艳, 蒋兰萍, 袁涛, 等. 氯离子清除试验在Gitelman综合征鉴别诊断中的应用[J]. 中国医学科学院学报, 2016, 38: 275-282. doi: 10.3881/j.issn.1000-503X.2016.03.006 |
[37]
|
Nozu K, Iijima K, Kanda K, et al. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies[J]. J Clin Endocrinol Metab, 2010, 95: E511-E518. doi: 10.1210/jc.2010-0392 |
[38]
|
张军, 陈秋莉, 李燕虹, 等. 呋塞米/氢氯噻嗪负荷试验在儿童Bartter综合征和Gitelman综合征鉴别诊断中的应用[J]. 临床儿科杂志, 2016, 34: 891-893. doi: 10.3969/j.issn.1000-3606.2016.12.003 |
[39]
|
Lin SH, Cheng NL, Hsu YJ, et al. Intrafamilial pheno-type variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotrans-porter[J]. Am J Kidney Dis, 2004, 43: 304-312. doi: 10.1053/j.ajkd.2003.10.018 |
[40]
|
Fukuyama S, Okudaira S, Yamazato S, et al. Analysis of renal tubular electrolyte transporter genes in seven patients with hypokalemic metabolic alkalosis[J]. Kidney Int, 2003, 64: 808-816. doi: 10.1046/j.1523-1755.2003.00163.x |
[41]
|
Lin SH, Shiang JC, Huang CC, et al. Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome[J]. J Clin Endocrinol Metab, 2005, 90: 2500-2507. doi: 10.1210/jc.2004-1905 |
[42]
|
Berry MR, Robinson C, Karet Frankl FE. Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements[J]. Nephrol Dial Transplant, 2013, 28: 1533-1542. doi: 10.1093/ndt/gfs600 |
[43]
|
Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life[J]. Kidney Int, 2001, 59: 710-717. doi: 10.1046/j.1523-1755.2001.059002710.x |
[44]
|
Tammaro F, Bettinelli A, Cattarelli D, et al. Early appearance of hypokalemia in Gitelman syndrome[J]. Pediatr Nephrol, 2010, 25: 2179-2182. doi: 10.1007/s00467-010-1575-1 |
[45]
|
Jiang L, Chen C, Yuan T, et al. Clinical severity of Gitelman syndrome determined by serum magnesium[J]. Am J Nephrol, 2014, 39: 357-366. doi: 10.1159/000360773 |
[46]
|
Larkins N, Wallis M, McGillivray B, et al. A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin[J]. Clin Kidney J, 2014, 7: 306-310. doi: 10.1093/ckj/sfu029 |
[47]
|
Jeck N, Schlingmann KP, Reinalter SC, et al. Salt handl-ing in the distal nephron: lessons learned from inherited human disorders[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288: R782-R795. doi: 10.1152/ajpregu.00600.2004 |
[48]
|
Liaw LC, Banerjee K, Coulthard MG. Dose related growth response to indometacin in Gitelman syndrome[J]. Arch Dis Child, 1999, 81: 508-510. doi: 10.1136/adc.81.6.508 |
[49]
|
Blanchard A, Vargas-Poussou R, Vallet M, et al. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome[J]. J Am Soc Nephrol, 2015, 26: 468-475. doi: 10.1681/ASN.2014030293 |
[50]
|
Peng X, Jiang L, Chen C, et al. Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome[J]. PLoS One, 2017, 12: e0180811. doi: 10.1371/journal.pone.0180811 |
[51]
|
Cho YJ, Park GT, Cho YJ, et al. Renal potassium wasting and hypocalciuria ameliorated with magnesium repletion in Gitelman's syndrome[J]. J Korean Med Sci, 1997, 12: 157-159. doi: 10.3346/jkms.1997.12.2.157 |
[52]
|
Robinson CM, Karet Frankl FE. Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes[J]. Nephrol Dial Transplant, 2017, 32: 508-512. http://ndt.oxfordjournals.org/content/early/2016/03/02/ndt.gfw019.full.pdf |
[53]
|
Hayashi M. Gitelman's syndrome and hypomagnesemia[J]. Intern Med, 2004, 43: 351-352. doi: 10.2169/internalmedicine.43.351 |
[54]
|
Ayuk J, Gittoes NJ. How should hypomagnesaemia be investigated and treated?[J]. Clin Endocrinol (Oxf), 2011, 75: 743-746. doi: 10.1111/j.1365-2265.2011.04092.x |
[55]
|
Sundram V, Daly E, Waldron M. Gitelman syndrome: Case report of a toddler following salbutamol inhaler[J]. Archives of Disease in Childhood, 2019, 104: A182. doi: 10.1136/archdischild-2019-epa.420 |
[56]
|
Tursi A. Gitelman syndrome triggered by proton-pump inhibitor use[J]. Dig Liver Dis, 2019, 51: 911. http://www.onacademic.com/detail/journal_1000042276219099_3327.html |
[57]
|
Yuan T, Jiang L, Chen C, et al. Glucose tolerance and insulin responsiveness in Gitelman syndrome patients[J]. Endocr Connect, 2017, 6: 243-252. doi: 10.1530/EC-17-0014 |
[58]
|
Blanchard A, Vallet M, Dubourg L, et al. Resistance to insulin in patients with Gitelman syndrome and a subtle intermediate phenotype in heterozygous carriers: a cross-sectional study[J]. J Am Soc Nephrol, 2019, 30: 1534-1545. doi: 10.1681/ASN.2019010031 |
[59]
|
Ren H, Qin L, Wang W, et al. Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome[J]. Am J Nephrol, 2013, 37: 152-157. doi: 10.1159/000346708 |
[60]
|
Knoers NV, Levtchenko EN. Gitelman syndrome[J]. Orphanet J Rare Dis, 2008, 3: 22. doi: 10.1186/1750-1172-3-22 |
[61]
|
Fujimura J, Nozu K, Yamamura T, et al. Clinical and Genetic Characteristics in Patients With Gitelman Syndrome[J]. Kidney Int Rep, 2018, 4: 119-125. |
[62]
|
Cruz DN. The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density?[J]. Nephrol Dial Transplant, 2001, 16: 691-694. http://ndt.oxfordjournals.org/content/16/4/691.2.full.pdf |
[63]
|
Nicolet-Barousse L, Blanchard A, Roux C, et al. Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null mice[J]. J Bone Miner Res, 2005, 20: 799-808. http://www.researchgate.net/profile/Anne_Blanchard2/publication/7911802_Inactivation_of_the_Na-Cl_co-transporter_%28NCC%29_gene_is_associated_with_high_BMD_through_both_renal_and_bone_mechanisms_analysis_of_patients_with_Gitelman_syndrome_and_Ncc_null_mice/links/5485a4190cf24356db6108f3.pdf |
[64]
|
Gutierrez M, Silveri F, Bertolazzi C, et al. Gitelman syndrome, calcium pyrophosphate dihydrate deposition disease and crowned dens syndrome. A new association?[J]. Rheumatology (Oxford), 2010, 49: 610-613. doi: 10.1093/rheumatology/kep324 |
[65]
|
Favero M, Calò LA, Schiavon F, et al. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases[J]. Best Pract Res Clin Rheumatol, 2011, 25: 637-648. doi: 10.1016/j.berh.2011.10.013 |
[66]
|
Iqbal Z, Sayer JA. Chondrocalcinosis and Gitelman syndrome[J]. QJM, 2016, 109: 563-564. doi: 10.1093/qjmed/hcw045 |
[67]
|
Viganò C, Amoruso C, Barretta F, et al. Renal phosphate handling in Gitelman syndrome-the results of a case-control study[J]. Pediatr Nephrol, 2013, 28: 65-70. doi: 10.1007/s00467-012-2297-3 |
[68]
|
Bouchireb K, Boyer O, Mansour-Hendili L, et al. Fan-coni syndrome and severe polyuria: an uncommon clinicobiological presentation of a Gitelman syndrome[J]. BMC Pediatr, 2014, 14: 201. doi: 10.1186/1471-2431-14-201 |
[69]
|
Balavoine AS, Bataille P, Vanhille P, et al. Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome[J]. Eur J Endocrinol, 2011, 165: 665-673. doi: 10.1530/EJE-11-0224 |
[70]
|
Zhou H, Liang X, Qing Y, et al. Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review[J]. BMC Endocr Disord, 2018, 18: 82. doi: 10.1186/s12902-018-0298-3 |
[71]
|
Miao Z, Gao Y, Bindels RJ, et al. Coexistence of normotensive primary aldosteronism in two patients with Gitelman's syndrome and novel thiazide-sensitive Na-Cl cotransporter mutations[J]. Eur J Endocrinol, 2009, 161: 275-283. doi: 10.1530/EJE-09-0271 |
[72]
|
Mishima E, Mori T, Sohara E, et al. Inherited, not acquired, Gitelman syndrome in a patient with Sjögren's syndrome: importance of genetic testing to distinguish the two forms[J]. CEN Case Rep, 2017, 6: 180-184. doi: 10.1007/s13730-017-0271-4 |
[73]
|
Elkoundi A, Kartite N, Bensghir M, et al. Gitelman syndrome: a rare life-threatening case of hypokalemic paralysis mimicking Guillain-Barré syndrome during pregnancy and review of the literature[J]. Clin Case Rep, 2017, 5: 1597-1603. doi: 10.1002/ccr3.1122 |
[74]
|
Srinivas SK, Sukhan S, Elovitz MA. Nausea, emesis, and muscle weakness in a pregnant adolescent[J]. Obstet Gynecol, 2006, 107: 481-484. doi: 10.1097/01.AOG.0000168450.72031.d4 |
[75]
|
Mascetti L, Bettinelli A, Simonetti GD, et al. Pregnancy in inherited hypokalemic salt-losing renal tubular disorder[J]. Obstet Gynecol, 2011, 117: 512-516. doi: 10.1097/AOG.0b013e3182075317 |
[76]
|
Moustakakis MN, Bockorny M. Gitelman syndrome and pregnancy[J]. Clin Kidney J, 2012, 5: 552-555. doi: 10.1093/ckj/sfs126 |
[77]
|
Gallagher H, Soar J, Tomson C. New guideline for perioperative management of people with inherited salt-wasting alkaloses[J]. Br J Anaesth, 2016, 116: 746-749. doi: 10.1093/bja/aew102 |